BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16596231)

  • 1. Chemosensitivity prediction in esophageal squamous cell carcinoma: novel marker genes and efficacy-prediction formulae using their expression data.
    Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Noguchi T; Kawahara K; Natsugoe S; Aikou T; Okazaki Y; Hayashizaki Y; Sato Y; Todo S; Hiyama E; Nishiyama M
    Int J Oncol; 2006 May; 28(5):1153-62. PubMed ID: 16596231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.
    Fumoto S; Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Hiyama E; Noguchi T; Nishiyama M
    Int J Oncol; 2008 Feb; 32(2):413-23. PubMed ID: 18202764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
    Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
    Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma.
    Pak KC; Lam KY; Law S; Tang JC
    Int J Mol Med; 2009 Jan; 23(1):121-9. PubMed ID: 19082515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.
    Ooyama A; Takechi T; Toda E; Nagase H; Okayama Y; Kitazato K; Sugimoto Y; Oka T; Fukushima M
    Cancer Sci; 2006 Jun; 97(6):510-22. PubMed ID: 16734730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
    Jung JJ; Jeung HC; Chung HC; Lee JO; Kim TS; Kim YT; Noh SH; Rha SY
    Genomics; 2009 Jan; 93(1):52-61. PubMed ID: 18804159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes.
    Tanaka T; Tanimoto K; Otani K; Satoh K; Ohtaki M; Yoshida K; Toge T; Yahata H; Tanaka S; Chayama K; Okazaki Y; Hayashizaki Y; Hiyama K; Nishiyama M
    Int J Cancer; 2004 Sep; 111(4):617-26. PubMed ID: 15239142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arpc1b gene is a candidate prediction marker for choroidal malignant melanomas sensitive to radiotherapy.
    Kumagai K; Nimura Y; Mizota A; Miyahara N; Aoki M; Furusawa Y; Takiguchi M; Yamamoto S; Seki N
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2300-4. PubMed ID: 16723437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment of cDNA microarray technology and analysis of gene expression profiles in human esophageal cancer cell line ECa109].
    Li P; Ling Z; Zhao J; Yang H; Huang Y; Zhao M; Dong Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):413-8. PubMed ID: 18610633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
    Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: clinical implications.
    Ashida A; Boku N; Aoyagi K; Sato H; Tsubosa Y; Minashi K; Muto M; Ohtsu A; Ochiai A; Yoshida T; Yoshida S; Sasaki H
    Int J Oncol; 2006 Jun; 28(6):1345-52. PubMed ID: 16685435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray.
    Zhang X; Lin P; Zhu ZH; Long H; Wen J; Yang H; Zhang X; Wang DF; Fu JH; Fang Y; Rong TH
    Cancer Genet Cytogenet; 2009 Oct; 194(1):23-9. PubMed ID: 19737650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells.
    Toshimitsu H; Hashimoto K; Tangoku A; Iizuka N; Yamamoto K; Kawauchi S; Oga A; Furuya T; Oka M; Sasaki K
    Cancer Lett; 2004 Jul; 211(1):69-78. PubMed ID: 15194218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents.
    Jung JJ; Jeung HC; Lee JO; Kim TS; Chung HC; Rha SY
    Oncol Rep; 2007 Sep; 18(3):593-9. PubMed ID: 17671706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas.
    Yamabuki T; Daigo Y; Kato T; Hayama S; Tsunoda T; Miyamoto M; Ito T; Fujita M; Hosokawa M; Kondo S; Nakamura Y
    Int J Oncol; 2006 Jun; 28(6):1375-84. PubMed ID: 16685439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative prediction of tumor response to neoadjuvant chemotherapy in breast cancer: novel marker genes and prediction model using the expression levels.
    Sano H; Wada S; Eguchi H; Osaki A; Saeki T; Nishiyama M
    Breast Cancer; 2012 Jan; 19(1):37-45. PubMed ID: 21437666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
    Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
    Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.